TwinStrand Duplex SequencingTM technology is broadly applicable to many genomic challenges across science and medicine.
Many of those under development are the result of partnerships with commercial, regulatory, or academic leaders. We selectively take on projects in drug development, genetic toxicology, basic biology, and other fields where we see a long-term opportunity for new products and advancing science.
TwinStrand Biosciences, Inc.
For Research Use Only. Not for use in diagnostic procedures.
©2023 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices
American Society of Hematology (ASH)
December 5-8, 2020 – Virtual
Poster Presentation
“Duplex Sequencing with Patient-Specific Hybrid Capture Panels Reveals Ultra-Low Frequency Measurable Residual Disease in Pediatric Acute Myeloid Leukemia”
Presented by Jake Higgins, Senior Scientist – December 6, 2020 7:00 a.m.-3:30 p.m. PST
